Clinical Trial Update: An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial in ovarian, primary peritoneal, or fallopian tube cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Female Genital Cancer
• Ovarian Cancer
• Pelvic Cancer
• Peritoneal Cancer

Snippet

Sponsor: Eli Lilly and Company | Conditions: Genital Neoplasms, Female, Fallopian Tube Neoplasms | Phase 3 | Status: COMPLETED | Results posted: 2010-09-09